Ospedale Ssan Gerardo
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invernizzi, Pietro
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Active, not recruiting
3
238
Europe, Canada, Japan, US, RoW
Linerixibat, Placebo
GlaxoSmithKline
Pruritus
10/24
01/25
LLSAT, NCT04167358 / 2019-003158-10: Linerixibat Long-term Safety, and Tolerability Study

Recruiting
3
251
Europe, Canada, Japan, US, RoW
Linerixibat
GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited
Cholestasis
02/27
02/27
VISTAS, NCT04663308: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Recruiting
2
200
Europe, Canada, US, RoW
Volixibat, SHP626, Placebo
Mirum Pharmaceuticals, Inc.
Primary Sclerosing Cholangitis
09/25
12/25
PBC322, NCT05151809: National Database on Primary Biliary Cholangitis

Recruiting
N/A
6000
Europe
Clinical information, Laboratory information, Biological samples
University of Milano Bicocca, Intercept Pharmaceuticals, Laboratoires Mayoly Spindler
Primary Biliary Cholangitis
01/29
01/29
AIH Database, NCT06078098: Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage

Recruiting
N/A
10000
Europe
Clinical Information, Laboratory information, Biological samples
University of Milano Bicocca
Autoimmune Hepatitis, Liver Disorder
03/34
03/34
NCT05618145: National Database on Primary Sclerosing Cholangitis (PSC)

Recruiting
N/A
6000
Europe
Clinical information
University of Milano Bicocca
Primary Sclerosing Cholangitis
10/32
10/32

Download Options